Heart inflammation more common among men following mRNA-based COVID-19 vaccination | News-Medical https://t.co/63hUNDdZYa

— JJ🇮🇪 (@tazalot1981) September 16, 2021

The Amulet IDE trial showed that the Amulet device was safe and effective at left atrial appendage occlusion. Learn more here: https://t.co/4eZA3ZhLBi #ESCCongress #cvLAAoccluder @AABavry @DLBHATTMD

— American College of Cardiology (@ACCinTouch) September 17, 2021

Proud to share our latest publication: "miR-181c predicts response to exercise training in #HFpEF" in #EJPC @ESC_Journals
Early stage research, but let me walk you through why this could be relevant for your #HFpEF patients! 🧵

📎https://t.co/yGaxH5hXlx#CardioTwitter pic.twitter.com/hk4wvjOmoz

— Andreas Gevaert (@AndreasGevaert) September 17, 2021

Thanks for buying! There’s still a role for textbooks in diseases where the knowledge is mostly experience. But now we have to start planning the 3rd edition! @mmartinezheart @HCMBeat @SpringerCardio @CSHeartResearch @tikuowens @jodieingles27 @4hcm @moiz_hafiz @AnkurKalraMD https://t.co/eYGDrdN8T5

— Srihari S. Naidu, MD (@SrihariNaiduMD) September 19, 2021

For Patients with Acute MI (STEMI, NSTEMI,ACS) who are found to have IDA but WITHOUT history of Overt GI bleeding
when do you do endoscopic evaluation?#GITwitter #CardioGI #CardioTwitter #IDA

— Kamran Mushtaq (@Doc_Kamran) September 20, 2021